Symphony Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Symphony Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,500	Closed	-$1.09M	–	526
2014 Q4	$1.09M	Sell	9,500 -7,500	-44%	-$909K	0.14%	158
2014 Q3	$2.66M	Buy	+17,000	New	+$2.46M	0.27%	82

Other funds holding SLXP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return